Antimicrobial resistance triggers race to develop phage alternatives

Start-ups and scientists are in a race against time to develop new therapies based on phages, tiny bacteria-destroying virus that have the potential to create an alternative to antibiotics.

Related Keywords

Germany ,Australia ,United Kingdom ,Tbilisi ,Georgia General ,Georgia ,Austria , ,Bethesda ,Pembrokeshire ,Russia ,France ,Brussels ,Bruxelles Capitale ,Belgium ,Russian ,Australian ,Austrian ,French ,Soviet ,German ,Josh Jones ,George Eliava ,Greg Merril ,Francesca Hodges ,Richard James ,Heather Fairhead ,Greg Clark ,Alexandros Pantalis ,Action Fund ,Scottish Health Technologies Group ,European Commission ,Drug Administration ,World Health Organisation ,Eliava Institute ,Technology Committee ,European Research Council ,World Antimicrobial Awareness Week ,Innovate United Kingdom ,Phico Therapeutics ,United Kingdom Based ,European Pharmacopeia ,Phage United Kingdom ,Adaptive Phage Therapeutics ,Horizon Europe ,Queen Astrid Military Hospital ,Georgia Based Eliava Institute ,United Kingdom Phage Therapy ,